RWD92 Persistence and Patterns of Exposure to Omalizumab in Patients With Asthma in France Between 2009 and 2019 (SOLAIR Study)
Dec 1, 2022, 00:00 AM
10.1016/j.jval.2022.09.2317
https://www.valueinhealthjournal.com/article/S1098-3015(22)04522-3/fulltext
Section Title :
Section Order :
11877
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)04522-3&doi=10.1016/j.jval.2022.09.2317